SEC Tracker
Get the app

Pluristem Therapeutics PLUR

Pluristem Therapeutics: quarterly report for the quarter ended Mar 31, 2019

Form
10-Q
Filed
Period
Importance
Notable
Document
10-Q
Exhibit 10.1
Material contract
Exhibit 10.2
Material contract
Exhibit 10.3
Material contract

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Pluristem Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. ProPhase Labs PRPH public float $15M, Jun 30, 2025
  2. Akari Therapeutics AKTX public float $15M, Jun 30, 2025
  3. X4 Pharmaceuticals XFOR public float $15M, Jun 30, 2025
  4. CalciMedica CALC public float $16M, Jun 30, 2025
  5. Lipocine LPCN public float $16M, Jun 30, 2025